Total Lignans From Leaves of Schisandra chinensis Improve Alzheimer's Disease Pathology Through the Nrf2/HO‐1/NLRP3 Pathway
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202500812 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Yi-Qiang Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China. Hauptthemen laut MEDLINE: Schisandra, Alzheimer Disease, Lignans, Neuroprotective Agents. Die Arbeit nennt 42 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a chronic neurodegenerative disorder, and activation of the NLRP3 inflammasome has been identified as one of the critical factors contributing to AD pathogenesis. Although previous studies have highlighted the neuroprotective effects of Schisandra chinensis lignans, it remains unclear whether total lignans extracted from the leaves of S. chinensis (TLS) can alleviate AD pathology by inhibiting the NLRP3 inflammasome. This study investigates the potential neuroprotective effects of TLS in streptozotocin (STZ)‐induced AD rats and its associated signaling pathways. UHPLC‐Orbitrap‐MS was utilized to identify and characterize the major chemical constituents in the extract leaves of S. chinensis . Cognitive function was assessed using the Morris water maze (MWM) test, whereas Nissl staining, immunohistochemistry (IHC), biochemical assays, enzyme‐linked immunosorbent assays (ELISA), and Western blot (WB) were utilized to analyze AD‐related pathological changes and metabolic processes. The results demonstrated that TLS significantly ameliorates cognitive impairment and reduces the accumulation of phosphorylated tau (p‐Tau). Further investigations revealed that TLS alleviates oxidative stress and inflammatory responses via modulation of the nuclear factor E2–related factor 2 (Nrf2)/heme oxygenase‐1 (HO‐1)/NLRP3 pathway. These findings suggest that TLS may hold potential therapeutic applications for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.
- Traditional Chinese Medicine Biological Genetics, Heilongjiang Province Double First-Class Construction Interdiscipline, Harbin, China.
- College of Agriculture, Northeast Agricultural University, Harbin, China.
ORCID-Profile: Bing-You Yang
Zitieren
APA
Zhang, Y. Q., Liu, Z. Y., Liu, X., Xu, W. X., Guan, W., Li, M. M., Chen, Q. S., Zhang, L. L., Kuang, H. X., Yang, B. Y., Zhang, H., & Liu, Y. (2025). Total Lignans From Leaves of Schisandra chinensis Improve Alzheimer's Disease Pathology Through the Nrf2/HO‐1/NLRP3 Pathway. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500812
Vancouver
Zhang YQ, Liu ZY, Liu X, Xu WX, Guan W, Li MM, et al. Total Lignans From Leaves of Schisandra chinensis Improve Alzheimer's Disease Pathology Through the Nrf2/HO‐1/NLRP3 Pathway. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500812
BibTeX
@article{Zhang2025,
author = {Zhang, Yi-Qiang and Liu, Zhen-Yun and Liu, Xiang and Xu, Wen-Xiang and Guan, Wei and Li, Meng-Meng and Chen, Qing-Shan and Zhang, Li-Li and Kuang, Hai-Xue and Yang, Bing-You and Zhang, Hao and Liu, Yan},
title = {Total Lignans From Leaves of Schisandra chinensis Improve Alzheimer's Disease Pathology Through the Nrf2/HO‐1/NLRP3 Pathway},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202500812}
}
EUVIMED